The Demineralized Bone Chips graft features a cortico-cancellous composition with a particle size range of 2–10 mm. Produced through controlled demineralization, freeze-drying, and terminal gamma sterilization, this product is available in various volumes to facilitate clinical application
The demineralization process exposes native BMPs and other bone-derived growth factors, enhancing the osteoinductive potential of the graft. The predominantly cancellous composition also provides an osteoconductive scaffold that supports cellular infiltration, vascularization, and new bone formation